ALK fears politicians will force pharma industry to foot pandemic bill
The pandemic was a massive expense for governments around the world, and the allergy firm’s CEO Carsten Hellmann sees signs that some governments might force the pharma industry to pick up the tab.
by ulrich quistgaard, translated by daniel pedersen
ALK suspects that governments in Europe are currently investigating how to offset the huge expenses incurred by the Covid-19 pandemic.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
ALK releases surprisingly strong quarterly figures
For subscribers
ALK expects to have approved peanut allergy vaccine in 2030
For subscribers
